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Abstract. The role of integrins in muscle differentia- 
tion was addressed by ectopic expression of integrin o~ 
subunits in primary quail skeletal muscle, a culture sys- 
tem particularly amenable to efficient transfection and 
expression of exogenous genes. Ectopic expression of 
either the human a5 subunit or the chicken et6 subunit 
produced contrasting phenotypes. The ot5-transfected 
myoblasts remain in the proliferative phase and are dif- 
ferentiation inhibited even in confluent cultures. In 
contrast, myoblasts that overexpress the or6 subunit ex- 
hibit inhibited proliferation and substantial differentia- 
tion. Antisense suppression of endogenous quail et6 ex- 
pression inhibits myoblast differentiation resulting in 
sustained proliferation. These effects of ectopic a  sub- 
unit expression are mediated, to a large extent, by the 
cytoplasmic domains. Ectopic expression of chimeric a 
subunits, ct5ex/6cyto  and a6ex/5¢yto,  produced phenotypes 
opposite to those observed with ectopic or5 or or6 ex- 
pression. Myoblasts that express a5ex/6mo show de- 
creased proliferation while differentiation is partially 
restored. In contrast, the et6ex/5¢yto  transfectants remain 
in the proliferative phase unless allowed to become 
confluent for at least 24 h. Furthermore, expression of 
human ct5 subunit cytoplasmic domain truncations, be- 
fore and after the conserved GFFKR motif, shows that 
this sequence is important in a5 regulation of differen- 
tiation. Ectopic c~5 and o~6 expression also results in 
contrasting responses to the mitogenic effects of serum 
growth factors. Myoblasts expressing the human et5 
subunit differentiate only in the absence of serum while 
differentiation of untransfected and ot6-transfected 
myoblasts is insensitive to serum concentration. Addi- 
tion of individual, exogenous growth factors to a5- 
transfected myoblasts results in unique responses that 
differ from their effects on untransfected ceils. Both 
bFGF or TGFI3 inhibit the serum-free differentiation of 
a5-transfected myoblasts, but differ in that bFGF stim- 
ulates proliferation whereas TGF-13 inhibits it. Insulin 
or TGF-ot promote proliferation and differentiation of 
ot5-transfected myoblasts; however, insulin alters myo- 
tube morphology. TGF-o~ or PDGF-BB enhance muscle 
ct-actinin  organization into myofibrils, which is impaired 
in differentiated or5 cultures. With the exception of 
TGF-ot, these growth factor effects are not apparent in 
untransfected myoblasts. Finally, myoblast survival un- 
der serum-free conditions is enhanced by ectopic ct5 ex- 
pression only in the presence of bFGF and insulin while 
TGF-et and TGF-~ promote survival of untransfected 
myoblasts. Our observations demonstrate (1) a specific- 
ity for integrin a  subunits in regulating myoblast prolif- 
eration and differentiation; (2) that the ratio of integrin 
expression can affect the decision to proliferate or dif- 
ferentiate; (3) a role for the et subunit cytoplasmic do- 
main in mediating proliferative and differentiative 
signals; and (4) the regulation of proliferation, differen- 
tiation, cytoskeletal assembly, and cell survival depend 
critically on the expression levels of different integrins 
and the growth factor environment in which the cells 
reside. 
role for the extracellular matrix (ECM)  t in the regu- 
lation of cell differentiation  and gene expression 
has  been  demonstrated  for  many  different  cell 
types (Adams and Watt,  1993; Damsky and Werb, 1992; 
Please address all correspondence to S. Sastry, Department of Cell and 
Structural Biology, 511 Morrill Hall, 505 S. Goodwin Avenue, Urbana, IL 
61801.  Tel.:  (217)  244-6135;  Fax:  (217)  244-1648.  e-mail:  S-SASTRY 
@UIUC.EDU 
1.  Abbreviations  used  in  this  paper.  BrdU,  5-bromo-2'-deoxyuridine; 
ECM, extracellular matrix; FACS, fluorescence-activated  cell sorting; FN, 
fibronectin; LM, laminin; UT, untransfected myoblast. 
Juliano and Haskill, 1993; Lin and Bissell,  1993). For in- 
stance, tissue-specific expression of milk proteins in mam- 
mary  epithelium  requires  adhesion  to  basement  mem- 
brane  components (Roskelley et al.,  1995)  and  terminal 
differentiation of keratinocytes involves changes in adhe- 
sion to fibronectin (FN), laminin (LM), and collagen (Ad- 
ams and Watt, 1990). However, the mechanisms by which 
the ECM regulates differentiation are currently poorly un- 
derstood. Skeletal muscle has served as a model system for 
defining the molecules and mechanisms which govern cell 
differentiation, including  its regulation by the ECM. A re- 
quirement  for  particular  ECM  components  in  skeletal 
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tions of the requirement of a matrix molecule for differen- 
tiation  (Hauschka  and  Konigsberg,  1966).  Adhesion  of 
muscle cells to extracellular matrix components influences 
such diverse phenomena  as cell migration,  the prolifera- 
tive  to  differentiative  transition,  muscle  morphogenesis, 
the organization of an elaborate contractile apparatus, and 
synapse formation (McDonald et al., 1995a). It is also ap- 
parent  that  other  types  of  exogenous  molecules,  e.g., 
growth factors, regulate muscle differentiation. For exam- 
ple, media rich in growth factors or the presence of bFGF 
inhibit  terminal  differentiation  and  stimulate  myoblast 
proliferation (Clegg et al., 1987). Conversely, the presence 
of insulin appears to promote differentiation  (Florini  and 
Magri, 1989). 
Integrins, which are dual receptors for the ECM and the 
cytoskeleton,  are  implicated  as  key players  in  many  as- 
pects  of  muscle  differentiation  and  development  (Mc- 
Donald  et al.,  1995a);  however, the role  of specific inte- 
grins  is  only  beginning  to  be  addressed.  Menko  and 
Boettiger  (1987)  demonstrated  that  antibody  ligation  of 
the [M integrin maintains chick myoblasts in the prolifera- 
tive state. Thus,  [M integrins  participate  in the transition 
from proliferation  to differentiation.  Several recent stud- 
ies  describe  the  expression  and  potential  functions  of a 
number  of  different  integrins  during  myogenesis.  The 
et5131 integrin localizes in adhesion plaques and displays a 
dynamic and regulated pattern of expression during termi- 
nal  differentiation  suggesting  an  important  role  in  the 
early events of myogenesis (Blaschuk and Holland,  1994; 
Boettiger et al., 1995; Enomoto et al., 1993; Lakonishok et 
al., 1992). The a4lM integrin is proposed to function in fu- 
sion  events  during  secondary  myogenesis  (Rosen  et  al., 
1992). The ~7131 integrin  localizes in myotendinous junc- 
tions  (MTJ)  (Bao  et  al.,  1993)  and  several  alternately 
spliced isoforms have been identified which are expressed 
in  skeletal  muscle  (Collo  et  al.,  1993;  Song  et  al.,  1992, 
1993; Ziober et al., 1993). The a3 and otv integrins colocal- 
ize with nascent myofibrils and with z-bands, respectively, 
and are thus likely to take part in myofibril organization 
(McDonald et al., 1995b). The a1131 (Duband et al., 1992), 
a6[M  (Bronner-Fraser  et al.,  1992), and ~t9[~1 (Palmer  et 
al.,  1993) integrins  are  also expressed in skeletal muscle; 
however  their  functions  have  not  been  identified.  Al- 
though the precise role of these a  subunits in muscle dif- 
ferentiation  remains  unclear,  the  existing  data  argue  for 
distinct roles for specific integrins during myogenesis. 
We addressed the role of integrins in muscle differentia- 
tion  by ectopic expression  of integrin  a  subunits  in pri- 
mary  quail  skeletal  muscle  cultures.  Primary  quail  myo- 
blasts offer many advantages for the ectopic expression of 
integrins.  They provide a relatively continuous  source of 
replicating  myoblasts that  are  amenable  to selection and 
cloning and can be stably transfected with high efficiency 
(DiMario et aL,  1993). Furthermore,  unlike many muscle 
cell lines which often exhibit abnormal or aborted devel- 
opment  (Antin  and  Ordahl,  1991), myogenic differentia- 
tion is more faithfully reproduced in primary muscle cul- 
tures. In addition, cloned quail myoblasts, introduced into 
chick  embryos,  incorporate  into  developing  embryonic 
muscle and are thus useful for in vivo studies (Stockdale et 
al.,  1990). Two ot subunits were chosen for these studies: 
the or5 subunit and the or6 subunit. Previous studies suggest 
that FN and LM play opposing roles in muscle differentia- 
tion (vonder Mark and Ocalan,  1989;  Kosher and Rodg- 
ers, 1987; Foster et al., 1987). The ot5131 and ~6131 integrins 
are specific receptors for FN and LM, respectively, making 
them attractive  candidates to mediate these different sig- 
nals.  Furthermore,  the a5 integrin  is implicated  in trans- 
membrane  signaling  and  gene  regulation  (Damsky  and 
Werb, 1992; Juliano and Haskill, 1993) and displays a dy- 
namic pattern of expression during muscle differentiation 
(Blaschuk  and  Holland,  1994;  Enomoto  et  al.,  1993;  La- 
konishok et al., 1992). The or6 integrin is also implicated in 
transmembrane  signaling  (Jewell et al., 1995;  Shaw et al., 
1993,  1995),  and  its  adhesive  function  often depends  on 
cell activation by phorbol esters (Delwel et al., 1993; Shaw 
et  al.,  1990).  In  addition,  the  c~6  subunit  is  expressed 
throughout  myogenesis (Bronner-Fraser  et al., 1992;  Mc- 
Donald et al., 1995a), suggesting that it plays an important 
role. 
With  this  system we show that  changes  in integrin  ex- 
pression have  dramatic  effects on myoblast proliferation 
and differentiation.  We first demonstrate  a specificity for 
subunit function during differentiation.  Ectopic expres- 
sion of the  a5  subunit  inhibits  differentiation  and  main- 
tains myoblasts in the proliferative phase while ectopic ct6 
expression  inhibits  proliferation  but  not  differentiation. 
Antisense suppression of endogenous quail or6 expression 
also inhibits differentiation  resulting in sustained prolifer- 
ation, suggesting that the ratios of integrin expression are 
important  in  the  decision  to  proliferate  or  differentiate. 
We also show that the effect of ectopic et5 or tx6 expression 
on proliferation  and  differentiation  is mediated by the et 
subunit cytoplasmic domain. Finally, we demonstrate that 
integrin regulation of myoblast proliferation and differen- 
tiation  depends  on  the  growth  factor  environment  in 
which the cells reside. The precise phenotype depends on 
the  specific  integrin  expressed  and  on  the  particular 
growth factor present. Taken together, our results point to 
an  integrated,  combinatorial  model  of  signaling  events 
that include growth factors and integrins  as regulators  of 
differentiation. 
Materials and Methods 
Primary Cell Culture 
Primary myoblasts were isolated from pectoralis muscle of nine day Japa- 
nese quail embryos as described (Konigsberg, 1979). Briefly, myoblasts 
were  dissociated  from muscle  tissue  with  0.1%  dispase  (Boehringer- 
Mannheim Corp., Indianapolis,  IN) in PBS. The cell suspension was fil- 
tered through a Sweeney filter; cells were seeded onto gelatin-coated tissue 
culture plates (0.1% gelatin in PBS). Myoblast cultures were maintained 
in complete myoblast medium (DMEM [Sigma Chem. Co., St. Louis, MO] 
containing 15% horse serum, 5% chick embryo extract, 1% petdstrep, and 
1.25 p.g/ml fungizone (GIBCO BRL, Gaithersburg, MD). Myoblasts were 
subcultured in trypsin-EDTA (0.06% trypsin, 0.02% EDTA) and used be- 
tween passages 1 and 10. 
Antibodies and ExtraceUular  Matrix Ligands 
The muscle a-actinin specific monoclonal  antibody  (mAb), 9A2B8, was 
kindly provided by D. Fishman (Cornell University, New York, NY) as a 
hybridoma supernatant.  The mAb, VIF4, which recognizes the human u5 
integrin  extracellular  domain was a gift of R. Isberg (Tufts University, 
Boston, MA). The chicken ct6 specific polyclonal antibody, ct6ex (de Cur- 
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San Francisco, CA). The mAb against the extracellular domain of the hu- 
man a6 integrin, 2B7 (Shaw et al., 1993),  was a gift of A. Mercurio (Har- 
vard Medical School, Boston, MA). The mAb against 5-bromo-2'-deoxy- 
uridine (BrdU)  was purchased from Sigma Chem. Co. Fibronectin was 
purified  from  human plasma by  affinity chromatography as  described 
(Ruoslahti et al., 1982).  Laminin was isolated from murine Englebreth- 
Holm-Swarm sarcoma as described (Kleinman et ai., 1982). 
Vector Construction and Site-directed Mutagenesis 
The human a5 eDNA (Argraves et al., 1987)  was kindly provided by Dr. 
L. Reichardt in the eukaryotic expression plasmid, pl3Apr-l-neo (Gun- 
ning et  al.,  1987)  and subcloned into  the eukaryotic expression vector, 
pRSVneo (Reszka et al., 1992), or into the retroviral plasmid 1654 (a gift 
of J. Majors, Washington University, St. Louis, MO) (Ghattas et al., 1991). 
All restriction enzymes were purchased from GIBCO-BRL. A  3'  1.2-kb 
HindllI-DraI  fragment of the eDNA was ligated  into pTZI8R  (USB, 
Cleveland, OH)  at HindlII  and SmaI sites in the polylinker.  A  1.2-kb 
HindlII-SalI fragment was then ligated to a 3.0-kb SalI-I-IindlII piece cor- 
responding to the 5' portion of the ct5 eDNA. The resulting 4.2-kb full- 
length et5  eDNA  fragment with  Sail  at  both  ends was subcloned into 
pTZ18R at the SalI site to amplify a5-SalI. The 4.2-kb a5 eDNA was then 
subcloned into pRSVneo at Sail in the sense orientation and into 1654 at 
XbaI in both the sense and antisense orientations. Proper insert orienta- 
tion was determined by restriction endonuclease digestion. The chicken 
ct6A eDNA (de Curtis et al., 1991) was also provided by Dr. L. Reichardt 
in two fragments, C1  and C5, in htl0 phage. The C1  and C5 fragments 
were excised with EcoRI and each cloned into pTZ18R at the EcoRI site 
in the polylinker. The C1 and C5 fragments were partially digested with 
EcoRI and completely digested with Sail, ligated to each other at EcoRI 
to produce a 3.4-kb full-length t~6-Sall  fragment and cloned into pRSV- 
neo at Sail. The chicken a6 antisense (ASa6) plasmid was constructed by 
excising the full-length et6 eDNA with KpnI, religating to pRSVneo, and 
screening for inverted orientation by restriction endonuclease digestion. 
The human a6A eDNA, in the expression plasmid pRc/CMV (Shaw et al., 
1993),  was a generous gift of Dr. A. Mercurio. The lacZ eDNA was a gift 
of Dr. R. Blackman (University of Illinois) and was cloned into pRSVneo 
at KpnI and Sail. 
Truncation mutants of the a5 cytoplasmic domain were generated as 
described (Hayashi et al., 1990) using the Muta-Gene ~  in vitro mutagen- 
esis kit (BioRad Labs., Hercules, CA). Oligonucleotides were synthesized 
at the University of Illinois Genetic Engineering Facility (Urbana, IL). For 
the a5GFFKR  deletion mutant, a 1.2-kb HindllI-Dral fragment, correspond- 
ing to the a5 cytoplasmic domain, was cloned into M13mpl8 using Hin- 
dlII and Sinai. To make the ct5~o deletion, a 2.5-kb XhoI-DraI fragment 
was cloned into M13mpl8 at Sail and Smal. Oligonucleotides were designed 
to create a BclI site, which contains an in-frame stop codon, at nucleotide 
positions 1023 and 1031 (before and after the conserved GFFKR sequence, 
respectively). Mutants were confirmed by restriction digestion of M13 clones 
with  BclI  and by single-stranded DNA  sequencing using the dideoxy- 
chain termination method according to the Sequenase  TM protocol (USB). 
The mutant a5 cytoplasmic domains were subcloned into pUC19 (USB) 
at HindllI and KpnI, and then into the full-length a5 eDNA in pl3Apr-neo 
using complete HindlII-partial NdeI digests. The integrity of subcloning 
into the 13-actin expression vector was verified by DNA sequencing. Full- 
length mutant a5 cDNAs were subcloned into pRSVneo using KpnI. 
Chimeric a Subunit Construction 
The ot5ex]ct6cyto chimeric ct subunit was created by cassette mutagenesis us- 
ing complementary oligonucleotides encoding the entire human a6A cy- 
toplasmic domain (Tamura et al., 1990)  with Hindlll sites engineered at 
both ends. This cassette was cloned into the or5 eDNA (in pl3Apr-neo) at 
the unique HindlII site which corresponds to the KL sequence of the a5 
cytoplasmic domain immediately upstream of the conserved GFFKR re- 
gion. Correct insert orientation was confirmed by DNA sequencing. To 
match the ct6A cytoplasmic domain sequence (Tamura et al., 1990), an et5 
fragment  containing  the  engineered  a6A  region  was  cloned  into 
M13mpl8 to mutate the KLGFFKR sequence to KCGFFKR using the 
Muta-Gene kit. To clone the a5ex/ct6~o hybrid cDNA into pRSVneo, a 
1.5-kb XhoI-NdeI fragment was inserted into pTZ18R-ct5 at unique XhoI 
and Ndel  sites in the et5 cDNA. The full-length ct5~x/ot6cyto eDNA was 
cloned into pRSVneo using KpnI. 
The a6~x/a5~o chimeric a  subunit was constructed by fusing the extra- 
cellular and transmembrane domains of the chicken a6 eDNA with the cy- 
toplasmic domain of the human et5 eDNA. A DraI site was created as a si- 
lent mutation at the sequence -FR- of the GFFKR region in both the a5 
(a5-DraI)  and a6  (a6-DraI)  cytoplasmic domains. A  1.2-kb  DraI-SalI 
fragment of the ~t5-DraI cytoplasmic domain was ligated with a  600-bp 
band from a BstXI complete-DraI partial digest of a6-DraI, and this 1.8- 
kb product was cloned into pRSVneo-a6 partially digested with SalI and 
completely with BstXl (New England Biolabs, Beverly, MA). To match 
the et5 cytoplasmic domain sequence exactly to the published sequence 
(Argraves et al., 1987),  the KCGFFKR sequence was changed to KI~_G- 
FFKR by site-directed mutagenesis as described above. The integrity of 
the gene fusion and mutagenesis were confirmed by DNA sequencing. 
Transfection and Flow Cytometry 
Replicating myoblasts (4 ×  105-5 ×  105 cells; passages 1-3) were plated on 
60-mm tissue culture plates coated with 0.1%  gelatin in complete myo- 
blast medium for 16-20 h. For both transient and stable transfections, 8 txg 
of plasmid DNA and 50 p,g of Lipofectamine  TM (GIBCO-BRL) in 0.3 ml 
of DMEM (Sigma) were added to myoblast cultures, and cells were incu- 
bated for 8-16 h  in complete myoblast medium. Transfected myoblasts 
were either washed with DMEM, refed with myoblast medium, and ana- 
lyzed for transient expression or were trypsinized and plated into selection 
medium (myoblast medium containing 0.5 mg/ml G418, GIBCO-BRL) on 
gelatin-coated tissue culture plates. The chicken a6, human ct6, and a6eX/ 
a5cyto transfections were selected and maintained on laminin-coated (20 
}xg/ml) tissue culture plates. Myoblasts were selected in 0.5 mg/ml G418 
medium for 7-12 d  and then maintained in myoblast medium containing 
0.2 mg/ml G418. 
Both transient and stable myoblast transfections were analyzed for sur- 
face expression by flow cytometry as described (George-Weinstein et al., 
1988). Briefly, cells were washed with PBS and detached from plates with 
0.02%  EDTA  in  calcium-magnesium free  Hepes-Hanks buffer  (CMF- 
HH). The human et5 and mutant a5 transfected myoblasts were stained 
with a human ct5 specific mAb, VIF4, at a 1:5 dilution of hybridoma super- 
natant in CMF-HH containing 5% goat serum (blocking buffer) followed 
by  an  FITC-labeled  sheep  anti-mouse  IgG  (Cappell,  Durham,  NC). 
Chicken a6A, a6ex/otSeyto, and antisense ct6-transfected cells were stained 
with a chick a6 specific polyclonal antibody, a6ex, at 20 p.g/ml in blocking 
buffer and FITC-labeled goat anti-rabbit IgG. Human a6-transfected myo- 
blasts were analyzed with the human a6 specific mAb, 2B7, at 10 ixg/ml in 
blocking buffer. Flow cytometry was performed on a EPICS  TM cell sorter 
(Coulter Electronics, Inc., Miami Lakes, FL) equipped with Cicero  TM soft- 
ware for data analysis. The human ct5-transfected myoblasts were sorted 
to enrich for a population that was >90% positive for human a5 expres- 
sion. To normalize cell surface expression levels, the a5cyto, a5GFFKR, 
and ct5~V6~to-transfected  ceils were sorted for surface expression profiles 
comparable to that of enriched a5 transfectants. The chicken a6-trans- 
fected cells were sorted from transient transfections while the a6~Va5crto 
myoblasts were sorted for similar expression as those enriched for chicken 
a6 overexpression. 
Proliferation, Differentiation, and Cell 
Survival Measurements 
Untransfected or transfected myoblasts were  trypsinized, washed twice 
with Puck's Saline G  (GIBCO-BRL),  and seeded onto fibronectin-(a5- 
transfected cells; 20  p~g/ml) or  laminin-(et6-transfected cells; 40  p.g/ml) 
coated 12-ram glass coverslips at a density of 1.6 ×  104 cells/cm  2 in com- 
plete  myoblast medium or  3,2  ×  104  cells/era  2 in  serum-free medium 
(DMEM +  2% bovine serum albumin) and cultured for indicated times. 
For  some experiments, myoblasts were  grown  in  low  serum  medium 
(DMEM  +  2%  horse serum). Growth  factors were  added  to  untrans- 
fected and a5-transfected myoblasts in serum-free medium at the time of 
plating  and twice  daily at concentrations of insulin (Sigma;  10 }xg/ml), 
bFGF (from S. Hauschka and Sigma; 10 ng/ml), TGF-I3 (Sigma; 1 ng/ml), 
TGF-ot (Calbiochem; 10 ng/ml), PDGF-BB (Sigma; 20 ng/ml). 
Myoblasts were immunostained for a muscle specific marker, muscle 
a-actinin, to determine the extent of biochemical differentiation and myo- 
fibrillar organization in the various transfectants. At the time points indi- 
cated, coverslips were washed with PBS and fixed with 3% formaldehyde 
in PBS for 15 rain. Cells were permeabilized with 0.2% Triton X-100 in 
PBS for 10 rain at room temperature, washed, and blocked in 5% goat se- 
rum-PBS for 30 min. Cells were incubated with primary antibody, 9A2B8, 
(a gift of D. Fishman) an mAb against muscle specific ct-actinin (at a  1:5 
dilution of hybridoma supernatant in 5% goat serum) for 30 rain, and then 
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loidin (Molecular Probes), and DAPI (1:2,000 dilution; Sigma) to stain the 
total  nuclei  for  an  additional  30  rain.  Coverslips  were  washed  and 
mounted in medium containing elvanol and p-phenylenediamine. Fluores- 
cence was observed on an Axioplan fluorescence microscope (Carl Zeiss, 
Inc., Thornwood, NY). The degree of morphological differentiation is ex- 
pressed as the fusion index, the percentage of total nuclei in myotubes, 
and was scored in three independent experiments for five random fields at 
the indicated time points. 
The fraction of proliferating cells was determined by measuring incor- 
poration of BrdU by myoblasts either in complete myoblast medium or in 
serum-free medium in the presence or absence of individual growth fac- 
tors. Ceils were seeded as described above in the appropriate medium and 
grown for 12, 24, 48, or 72 h. BrdU (50 ~M in DMEM) was added to cul- 
tures for 12 h  before fixation at indicated time points. Coverslips were 
fixed for 10 min in 95% ethanol, washed, denatured in 2N HCI for 30 min, 
and immunostained  with an anti-BrdU mAb (Sigma) at a 1:750 dilution in 
5% goat serum followed by FITC-sheep anti-mouse IgG and DAPI. The 
percentage of proliferating ceils, the fraction of total nuclei immunoposi- 
tive for BrdU, was scored for five random fields in three independent ex- 
periments. Cell survival for untransfected and a5-transfected myoblasts in 
serum-free medium or in serum-free medium including growth factors is 
expressed as a ratio of the average number of nuclei per field in the pres- 
ence or absence of growth factor to the average number of nuclei per field 
in serum-free medium alone after 24 h. The data were calculated for five 
random fields in three independent experiments. 
Results 
Ectopic Expression  of Integrin  ~ Subunits 
in Primary Muscle 
The role of integrins in myogenesis was addressed by ec- 
topic expression of integrin a  subunits  in  primary quail 
skeletal muscle cultures. These cells transfect stably with 
high efficiency (DiMario et al., 1993) and most aspects of 
muscle differentiation are faithfully reproduced in culture. 
We chose initially to express the a5 and e~6 subunits of in- 
tegrin because  they are implicated in myogenesis (Blas- 
chuk and Holland, 1994; Boettiger et al.,  1995; Bronner- 
Fraser et al., 1992; Enomoto et al., 1993; Lakonishok et al., 
1992),  signal  transduction  events  (Damsky  and  Werb, 
1992; Jewell et al., 1995; Juliano and Haskill, 1993; Shaw et 
al., 1995)  and the control of cell proliferation (Giancotti 
and Ruoslahti, 1990; Sager et al., 1993; Varner et al., 1995). 
Replicating,  primary  quail  myoblasts  were  transfected 
with the expression plasmids, 1654 (Ghattas et al., 1991) or 
pRSVneo (Reszka et al., 1992), containing either the hu- 
man a5 cDNA, the chicken a6 cDNA, or a  lacZ control 
cDNA as well as a neomycin resistance gene as a select- 
able marker. The lacZ transfection served as a control for 
both neomycin selection and for ectopic expression of a 
foreign gene. Transfected cells were analyzed for surface 
expression by flow cytometry using a  subunit specific anti- 
bodies  as  described in  Materials  and  Methods.  The a5- 
transfected myoblasts were analyzed with a human a5 spe- 
cific mAb, VIF4, while overexpression of the et6 subunit 
was  detected with a  polyclonal chicken a6  specific anti- 
body, ot6ex, which recognizes both the endogenous quail 
a6 subunit and the transfected chicken or6 subunit. 
As shown in Fig. 1, both integrin ot subunits were effi- 
ciently expressed on the cell surface at high levels 48-72 h 
after transfection. The human or5 (ha5) subunit was ex- 
pressed in 60-80% of the cells (Fig. 1 A). Similar expres- 
sion levels were obtained with both the 1654-a5 and pRS- 
Vneo-a5  plasmids.  The chicken a6  subunit was  initially 
expressed at levels 2--4-fold greater than the endogenous 
Figure 1. Ectopic expression of integrin a subunits in primary mus- 
cle. Primary quail myoblasts were transfected with the human et5 
(her5) subunit (A), the chicken et6 (chet6) subunit (B), the human 
c~6 (her6) subunit (C), or antisense chicken et6 (ASct6) (D) and an- 
alyzed for transient cell surface expression by flow cytometry. All 
subunits are efficiently expressed by 48 h after transfection. Ec- 
topic integrins were detected with ct subunit specific antibodies. 
(A) The ha5 specific mAb, VIF4, does not cross react with un- 
transfected  myoblasts  (UT) and is specific for the transfected 
subunit.  (B and D)  Untransfected,  cha6, or ASet6-transfected 
myoblasts were stained  with the chicken  et6 specific antibody, 
ct6ex, which recognizes both the endogenous quail ct6 (qa6) sub- 
unit and the transfected cha6 subunit. (B) The shift in the cha6 
profile represents the total et6 integrin expressed on the cell sur- 
face. (D) Expression of the qtx6 subunit is efficiently suppressed 
by ASa6 five days after transfection.  A nonspecific rabbit IgG 
(RIgG) was used as a negative fluorescence control on untrans- 
fected myoblasts. (C) The 2B7 mAb is specific for the h~t6 sub- 
unit and does not react with untransfected myoblasts (UT). 
quail a6 subunit based on comparison of the mean fluores- 
cence intensities of chicken ot6-transfected myoblasts (mean 
fluorescence intensity  =  44)  and  untransfected controls 
(mean fluorescence intensity =  15) (Fig. 1 B). Since pri- 
mary quail myoblasts are amenable to selection and clon- 
ing, the her5- and chicken ot6-transfected cells were placed 
in myoblast medium containing G418 to generate stable 
populations of myoblasts that expressed her5 or chicken 
a6. Resistant colonies were pooled and analyzed by flow 
cytometry for surface expression. The her5 subunit was sta- 
bly expressed on the cell surface in 50--80%  of neomycin- 
resistant cells. This level of expression persisted through- 
out the lifetime of the cells in culture. For the experiments 
described below, the hot5-transfected cells were enriched 
by fluorescence-activated cell sorting  (FACS)  to  obtain 
populations that were 80-90% positive for hot5 expression 
(See Fig. 6 A). 
In contrast to the hot5 subunit, we were unable to consis- 
tently and reproducibly obtain a myoblast population that 
stably overexpressed the chicken a6 subunit. FACS analy- 
sis showed that chicken et6 expression is lost after 72 h (not 
shown). This instability of or6 expression is not observed in 
QT6 fibroblasts or in NIH 3T3 cells where the chicken et6 
subunit is expressed after G418 selection and cell sorting 
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Figure 2.  Effect of ectopic ~t5 (A) and a6 expression  (B), ASot6 
suppression  (B), and cytoplasmic  domain alterations (A and B) 
on morphological differentiation.  Untransfected (UT) and trans- 
fected myoblasts were grown in complete myoblast medium for 
times indicated  and immunostained with phalloidin  to mark the 
myotubes and DAPI to visualize the nuclei. The fusion index, the 
percentage of nuclei  residing  in  multinucleated  myotubes, was 
scored for five random fields and represents an average of three 
independent experiments.  The error bars were calculated  as the 
standard deviations  for different fields. (A) Untransfected myo- 
blasts  (UT) exhibit  substantial  fusion after 72 h on an FN sub- 
strate. Ectopic a5 or a5GFFKR expression  inhibits  fusion after 
72 h whereas myoblasts expressing a5Acyto or ~t5ex/6¢yto fuse to a 
similar extent as the untransfected controls.  (B) On an LM sub- 
strate, untransfected cells show significant fusion after 72 h. Ceils 
expressing  chicken  c~6 fuse to a  similar  extent  as the untrans- 
fected controls while ASet6 suppression  inhibits fusion. The a6ex/ 
5~o subunit  inhibits fusion in 48-h cultures.  After 72-96 h, con- 
fluent  cultures  of et6eV5cyto-transfected myoblasts fuse into myo- 
tubes. 
(not shown). To confirm these results with the chicken et6 
subunit, we transfected the human or6 (hot6)  cDNA in the 
expression plasmid, pRc/CMV, which expresses in a num- 
ber of other cell types  (Delwel  et al.,  1993;  Shaw et al., 
1993).  Expression of the ha6 subunit was also unstable in 
primary quail myoblasts. The hot6 subunit was initially ex- 
pressed in 80% of G418-resistant cells (Fig. 1 C) at a level 
comparable to the hot5 subunit. However, this expression 
was  lost  after  about  six  to  seven  days  in  culture  (not 
shown). Thus, the instability of or6 expression appears to 
be unique to some cell types or primary cells and does not 
appear to  be a  DNA  subcloning artifact. Therefore, for 
most experiments, we relied on cell sorting to enrich tran- 
sient populations which overexpressed chicken or6 or per- 
formed experiments with h~6 expressing myoblasts during 
a  window of 1-5 d  after G418 selection when expression 
was still present on the cell surface. 
The ct5 and a6 Integrins Act Reciprocally  to Regulate 
Muscle Proliferation  and Differentiation 
Ectopic expression of the  or5 and ct6 integrins produced 
dramatic as well as contrasting effects on myogenesis, the 
earliest and most striking of which is the effect on the tran- 
sition between myoblast proliferation and differentiation. 
In a rich medium containing a high concentration of horse 
serum  and  embryo  extract,  control,  untransfected  myo- 
blasts (UT) initially replicate, and after 48 or 72 h, a signif- 
icant fraction of the cells undergo differentiation, as deter- 
mined  by  both  biochemical  and  morphological  criteria 
while  the  remainder of the  cells continue  to proliferate. 
Approximately 50% of the total nuclei are found in multi- 
nucleated  myotubes by 72 h  (Fig. 2 A). The majority of 
these cells express muscle specific markers, such as muscle 
ot-actinin, which organize into myofibrils in a striated pat- 
tern by 72 or 96 h  (Fig. 3 A). Myoblasts transfected with a 
control lacZ plasmid differentiate indistinguishably from 
UT controls (not shown) demonstrating that expression of 
a  foreign gene per se does not influence proliferation or 
differentiation. 
Ectopic expression of the hot5 integrin inhibits differen- 
tiation and maintains myoblasts in the proliferative phase. 
The  hot5-transfected  myoblasts proliferate  in  clusters  to 
form a monolayer with little detectable fusion or biochem- 
ical differentiation. The effect of ectopic ct5 expression on 
myoblast proliferation  was  quantitated  by the  ability of 
both  untransfected  and  ha5-transfected  myoblasts to  in- 
corporate  the  thymidine  analogue  5-bromo-2'-deoxyuri- 
dine (BrdU). The percentage of labeled nuclei reflects the 
fraction of cells that progress through  the  cell cycle and 
thus proliferate. As shown in Fig. 4 A, untransfected and 
ha5-transfected myoblasts initially proliferate to a similar 
extent after 24 h. Whereas the rate of BrdU incorporation 
decreases to ~50% in the untransfected controls after 48 h, 
presumably due to withdrawal from the cell cycle by termi- 
nal differentiation,  80-90%  of ht~5-transfected myoblasts 
remain in the proliferative phase. After 72 h  the percent- 
age of nuclei  in  hoL5-transfected myoblasts that  incorpo- 
rate BrdU decreases, most likely due to density-dependent 
inhibition of growth. However, as shown in Fig. 2 A  and 
Fig. 3 B, the ha5-transfected myoblasts do not differenti- 
ate. Fewer than 5 % of the h~t5-transfected myoblasts fuse 
into myotubes (Fig. 2 A) or express muscle ot-actinin (Fig. 
3  B)  after 72 h  in culture.  Although  the h~5-transfected 
myoblasts do  not  differentiate,  they  are  myogenic since 
they express the L4 antigen, a cell surface marker for the 
myogenic lineage  (not  shown)  (George-Weinstein  et al., 
Sastry et al. lntegrin/Growth  Factor Regulation of  Differentiation  173 Figure 3.  Muscle a-actinin expression and organization in myoblasts transfected with the ha5 subunit or the hct5 subunit with an altered 
cytoplasmic domain. Untransfected and transfected myoblasts were cultured for 72 h on FN-coated coverslips in complete myoblast me- 
dium and immunostained with a muscle a-actinin specific mAb, 9A2B8 (A-C, D, and E). In B' and C', cells were costained for actin 
with rhodamine phalloidin to mark the location of the cells in B and C. (A) Untransfected myoblasts fuse into myotubes, express muscle 
ct-actinin, and organize it into a striated pattern. (B and B') Ectopic expression of the hct5 integrin inhibits differentiation. Note that 
muscle ¢x-actinin is not expressed (B) and actin costaining (B') shows that hc~5-transfected myoblasts are not fused into myotubes. (C 
and C') Ectopic expression of a truncated hct5 subunit, Ct5orexR, which retains the conserved GFFKR region, inhibits differentiation. 
Muscle a-actinin expression is not detected (C) and the cells do not fuse into myotubes (C'). (D) Myoblasts transfected with the ot5ex/ 
6tyro subunit differentiate after 72 h. They fuse into myotubes and express and organize muscle et-actinin in striations.  (E) Ectopic ex- 
pression of an ha5 subunit with a deletion of its entire cytoplasmic domain, ccSAcyto,  does not inhibit differentiation. Note the presence 
of myotubes and muscle a-actinin. However, muscle a-actinin is not organized in clear striations.  Bars: (B, B', C, and C') 50 I~m; (A, D, 
and E) 30 i~m. 
1988). To determine if the effect of ectopic et5 expression 
on myoblast proliferation and differentiation is specific for 
the  transfected  subunit,  we  expressed  a  human  or5  anti- 
sense plasmid containing the full-length human et5 cDNA 
in an inverted orientation to inhibit the ectopic et5 expres- 
sion. In FACS enriched cells, human et5 expression was ef- 
ficiently suppressed  (to  undetectable  levels)  by the  anti- 
sense construct (not shown), and restored a differentiation 
phenotype to the cells closely resembling that of untrans- 
fected myoblasts (not shown). 
The inability to obtain a stable population of myoblasts 
expressing the chicken a6 or human a6 subunits suggested 
that  overexpression  of this  integrin  subunit  inhibits  cell 
proliferation. To test this, we determined the ability of myo- 
blasts  transiently  expressing  the  hot6 subunit  to incorpo- 
rate BrdU. Under similar growth conditions  (density and 
serum concentration) as the hot5-transfected cells, only 5-10% 
of myoblasts expressing hot6 incorporate BrdU after 24 h 
(Fig. 4 B). This contrasts both the untransfected  controls 
(Figure  4, A  and  B)  and  the  het5-transfected  myoblasts 
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Figure 4.  Effect of ectopic or5 
(A)  and  a6  expression  (B), 
ASet6  suppression  (B),  and 
cytoplasmic  domain  alter- 
ations  (,4,  C,  and  D)  on 
myoblast  proliferation.  Un- 
transfected  and  transfected 
myoblasts  were  grown  in 
complete  myoblast  medium 
for 12, 24, 48, and 72 h. Cul- 
tures  were  labeled  with  50 
ixM  5-bromo-2'-deoxyuri- 
dine (BrdU) for 12 h before 
fixation at the indicated  time 
points.  The  nuclei  incorpo- 
rating  BrdU  were  detected 
by  immunostaining  with  an 
anti-BrdU mAb and  all nu- 
clei  were  visualized  with 
DAPI.  The  percentage  of 
BrdU  incorporation  was 
scored  from  five  random 
fields and represent an aver- 
age of three independent ex- 
periments.  The  error  bars 
correspond  to  the  standard 
deviation of percentage of la- 
beled  nuclei  for  different 
fields. (A) Untransfected (UT) 
and  hct5-transfected  myo- 
blasts initially proliferate similarly for 24 h. After 48 h, ectopic a5 expression maintains myoblasts in the proliferative phase while prolif- 
eration of untransfected myoblasts decreases.  Proliferation in myoblasts expressing the ct5ex]6eyto  subunit is retarded. (B) Ectopic hct6 
expression  inhibits proliferation while ASa6 suppression  or expression of the a6ex/5~o subunit maintain myoblasts in the proliferative 
phase. (C) Myoblasts transfected with the a5Acyto truncation proliferate much like the untransfected controls,  (D) Myoblasts express- 
ing a5GFFKR remain in the proliferative phase resembling ha5-transfected myoblasts. 
(Fig. 4 A) where 80% of the nuclei incorporate BrdU after 
24 h. Ectopic or6 expression does not measurably affect the 
extent of biochemical or morphological differentiation which 
parallels that observed in untransfected controls cultured 
on a  laminin substrate. At 72 h, 45-50% of untransfected 
myoblasts fuse into myotubes (Fig. 2 B) and muscle et-acti- 
nin is expressed and organized in striations (Fig. 5 A). Myo- 
blasts that overexpress chicken et6 differentiate within 48- 
72  h  after cell  sorting.  Nearly 40%  of the  enriched  et6- 
transfected cells fuse into myotubes after 72 h  (Fig. 2 B). 
Furthermore, they express and organize muscle a-actinin 
into striations (Figure 5 D). Thus, in direct contrast to the 
hct5  subunit,  ectopic ct6  expression  inhibits  proliferation 
but not differentiation. 
Since overexpression of the or6 subunit  inhibited  myo- 
blast proliferation, we next transfected an antisense (AS) 
chicken et6 cDNA plasmid to inhibit endogenous quail et6 
(qet6) expression. The ASa6 construct reduces surface ex- 
pression of the qct6 subunit to 75% of normal levels after 5 d 
(Fig.  1 D). This reduction of a6 expression results in en- 
hanced proliferation  and  inhibited  differentiation;  an ef- 
fect opposite to that of a6 overexpression. As illustrated in 
Fig. 4 B, 90% of myoblasts with reduced a6 expression in- 
corporate BrdU after 24 h, and this rate of incorporation 
persists for 48  or 72 h.  These cells also exhibit inhibited 
differentiation. Fewer than 5% of the nuclei reside in myo- 
tubes (Fig. 2 B) and muscle ot-actinin is not expressed in 
the majority of the cells (Fig. 5 B). 8-10 d  after transfec- 
tion,  the  level of qa6  expression  returns  to  endogenous 
levels, and the cells differentiate similarly to UT myoblasts 
(not  shown).  Therefore, suppression  of quail ct6 expres- 
sion, like ectopic expression of the ct5 subunit, inhibits myo- 
blast  differentiation  resulting  in  sustained  proliferation. 
The overexpression and antisense results together suggest 
that specific integrins may be critical in the transition be- 
tween myoblast proliferation and differentiation and that 
the relative expression levels, i.e., ratios, of different inte- 
grins are important in this decision. 
The Effects of  Ectopic tr5 and a6 Expression Are 
Mediated by the Cytoplasmic Domains 
The contrasting effects of ectopic et5 and a6 expression on 
proliferation and differentiation demonstrate a specificity 
for integrin et subunits in regulating muscle differentiation. 
Since integrin ~  subunits possess distinct cytoplasmic do- 
mains (Sastry and Horwitz, 1993), it is likely that the spec- 
ificity of signals  transmitted  by different integrin  et sub- 
units  resides  in  the  cytoplasmic  domains.  To  test  this 
possibility, the cytoplasmic domains of the human ct5 sub- 
unit and the chicken or6 subunit were exchanged to make 
chimeric et subunits, otaex/6cyto  or ot6ex/5~o. The chimeric a 
subunits were stably expressed on the cell surface as deter- 
mined by flow cytometry. The ot5ex/6cyto subunit was sorted 
for comparable surface expression levels as the hct5  sub- 
unit (Fig. 6 D). The ct6ex/5cyto subunit,  unlike the chicken 
Sastry  et al. Integrin/Growth Factor Regulation of Differentiation  175 Figure 5.  Muscle a-actinin expression  and organization  in untransfected myoblasts (A) or myoblasts transfected with the chicken et6 
subunit (D), the et6eX/5cyto  chimeric subunit (C and E), or ASet6 (B). Untransfected (UT) or transfected myoblasts were cultured on LM- 
(UT, chicken et6, and et6ex/5~o) or FN (ASet6)-coated coverslips in complete myoblast medium for indicated  times and immunostained 
for muscle a-actinin (A-C, D and E) or phalloidin  (B' and C 0. (A) Untransfected cells differentiate and fuse into myotubes after 72 h 
on an LM substrate.  Muscle et-actinin is expressed and organized in striations.  (B) Antisense suppression  of endogenous et6 expression 
inhibits differentiation.  Muscle ~x-actinin expression is not detected in 72-h cultures  (B) and fusion into myotubes is inhibited  (B 0- (D) 
Ectopic expression of the chicken et6 subunit does not inhibit myotube formation or muscle et-actinin expression and organization in 72-h 
cultures. (C) Expression of a chimeric subunit, ct6ex/5cyto, inhibits myogenic differentiation in subeonfluent,  48-h cultures. Muscle a-acti- 
nin expression (C) and myotube formation (C 0 are not observed. (E) After 96 h, confluent cultures of a6erd5cyto-transfected  myoblasts 
differentiate and fuse into myotubes; but muscle c~-actinin  is not organized in clear striations. Bars: (B, B ', C, and C o 50 v,m; (A, D, and 
E) 30 ~m. 
a6 subunit, was stably expressed and was sorted for an ex- 
pression level similar to that in myoblasts transiently over- 
expressing the chicken et6 subunit (Fig. 6 E  and F). 
Ectopic  expression  of et5°x/6~o  or  ot6ex/5cyto  produces 
unique  effects on myoblast proliferation and  differentia- 
tion. Under similar growth conditions, the et5¢x/6~yto-trans  - 
fected myoblasts exhibit inhibited proliferation when com- 
pared to myoblasts transfected with the her5 subunit. BrdU 
incorporation shows that cells expressing tx5~x/6~yto  remain 
in a  prolonged lag phase for 48 h  compared to both un- 
transfected and ha5-transfected controls in which 80% of 
the cells proliferate within 24 h  (Fig. 4 A). Furthermore, 
replacement of the a5 cytoplasmic domain with the or6 cy- 
toplasmic domain reverses the inhibition of differentiation 
observed in het5-transfected myoblasts. 40%  of the ot5~x/ 
6cyto-transfected cells fuse  into  multinucleated  myotubes 
after 72 h (Fig. 2 A). These cells also express muscle et-acti- 
nin which organizes in a striated pattern after 72 h  (Fig. 3 
D). These results demonstrate that  the a5~x/6cyto subunit 
inhibits  rnyoblast  proliferation  but  not  differentiation. 
Thus, the a5~x/6cyto-transfected  myoblasts tend to behave 
similarly, but not identically, to myoblasts overexpressing 
the a6 subunit. 
Myoblasts  expressing  the  reverse  construct,  et6~X/5cyto, 
exhibit  density-dependent  proliferation  and  differentia- 
tion. As shown in Fig. 4 B, 85% of these cells incorporate 
BrdU after 24 h, and this level is maintained for 48 h. In 
addition, fewer than 5% of the nuclei reside in myotubes 
(Fig.  2  B)  and  muscle  et-actinin  expression  is  inhibited 
(Figure  5  C).  If the  ot6ex/5cyto-transfected  myoblasts  are 
The Journal of Cell Biology, Volume 133, 1996  176 Figure 6.  Surface expression levels of the hc~5 subtmit (A), the chicken a6 subunit (E), ha5 cytoplasmic domain truncations (B and C), 
and chimeric subunits a5eV6~o (D) and a6ex/5~o (F) in transfected myoblasts used in experiments.  Myoblasts were transfected with the 
pRSVneo plasmid containing  the h{x5 or chicken a6 integrin  cDNAs or cytoplasmic domain mutants and selected for comparable ex- 
pression levels by fluorescence-activated cell sorting (FACS) to normalize receptor numbers for use in experiments.  (A) Myoblasts sta- 
bly expressing the hc~5 subunit on the surface were sorted by FACS to enrich for a population that was 80-90% positive for ha5 expres- 
sion. Myoblasts transfected with the a5Aeyto truncation (B), the cx5GFFKR truncation (C), and the ~5ex/6~o chimeric subunit (D) were 
sorted by FACS for comparable surface expression profiles to that of enriched ha5-transfected myoblasts. (F) Myoblasts stably express- 
ing the chimeric subunit, a6ex/5~o, were sorted for similar surface expression as cells transiently overexpressing the chicken a6 subunit (E). 
subcultured, they remain in the proliferative phase for the 
life of the cells in culture as discussed above for myoblasts 
transfected with the  ha5 subunit.  However, if these ceils 
are allowed to remain confluent for 24--48 h, they undergo 
synchronous differentiation and 40% of the nuclei reside 
in  myotubes  (Fig.  2  B).  While  muscle  et-actinin  is  ex- 
pressed,  it is not  organized in  striations  even after 96  h 
(Figure  5  E).  This  contrasts  the  untransfected  controls 
(Fig.  5 A)  or myoblasts transfected with the  chicken ct6 
subunit (Fig. 5 D) in which muscle a-actinin appears stri- 
Sastry et al. lntegrin/Growth Factor Regulation of  Differentiation  177 Figure 7.  Effect of exogenous growth factors  on muscle a-actinin expression and organization in hct5-transfected  myoblasts. Untrans- 
fected (A) or hct5-transfected  myoblasts (B-G) were cultured on FN-coated coverslips under serum-free conditions  in the presence (C- 
G) or absence (A and B) of individual  growth factors. At indicated time points, cells were immungstained  with the mAb, 9A2B8, which 
recognizes muscle a-actinin (A-C, E, and G) or double immunostained  for muscle c~-actinin  (D and F) and actin (D' and F') to mark the 
location of the cells. (A) Untransfected myoblasts fuse into myotubes and express  and organize muscle ct-actinin into striations after 
The Journal  of CeU Biology,  Volume 133, 1996  178 Table I. Summary of  lntegrin a Subunit and Cytoplasmic 
Domain Effects on Muscle Differentiation 
Transfected  Myoflbdl 
subunit  Proliferation  Differentiation  assembly 
human  ~t5  +  -  NA 
chicken or human  a6  -  +  + 
AS a6  +  -  NA 
c~5ex/6cyto  -  +  + 
ct6ex/5cyto  +  -  *  -  * 
a5Acyto  +  +  - 
~SG~a ~  +  -  NA 
+, denotes that cells proliferate, differentiate, or have organized myofibrils. 
-,  denotes  that  cells exhibit greatly inhibited  proliferation,  differentiation,  or myo- 
fibril organization. 
NA, not applicable. 
*Differentiate if maintained confluent for 24-48  h, however, muscle a-actinin does 
not striate. 
ated within 72 h. Thus, myoblasts expressing the ot6ex/5~yto 
subunit exhibit a phenotype which tends to resemble that 
of the ha5 subunit. These results further show that the cy- 
toplasmic domain of the ~t5  subunit  positively regulates 
proliferation whereas  the  o~6  cytoplasmic domain  nega- 
tively regulates it. 
The Conserved GFFKR Region Is Important in od 
Regulation of  Differentiation 
We next localized active regions of the et5 cytoplasmic do- 
main  through  ectopic expression of cytoplasmic domain 
truncation mutants. Since integrin cytoplasmic domains share 
a highly conserved membrane proximal motif, KXGFFKR, 
that is implicated in the regulation of a  subunit function 
(O'Toole et al.,  1991), we expressed truncation mutants 
that retained only this sequence (et5OFFr,  R) or that deleted 
the  entire cytoplasmic domain  (o~5Acyto). Both of these 
cytoplasmic domain mutants  were  efficiently and  stably 
expressed on the cell surface as determined by flow cytom- 
etry. To normalize surface receptor numbers,  myoblasts 
expressing et5cyto or Ct5GFFKR were sorted by FACS  to 
obtain populations with surface expression profiles com- 
parable to that of the ha5 subunit (Fig. 6, B  and C). Ec- 
topic expression of these two deletion mutants resulted 
in  contrasting  phenotypes.  As  shown  in  Fig.  4  C,  the 
a5Acyto-transfected myoblasts incorporate BrdU to a sim- 
ilar extent as untransfected and hot5-transfected controls 
after 24 h. Whereas 80% of myoblasts expressing the her5 
subunit remain in the proliferative phase after 48 h, BrdU 
incorporation decreases to 50%  in  myoblasts expressing 
the et5cyto truncation much like in the untransfected con- 
trol. After 72 h,  myoblasts expressing ct5Acyto fuse into 
myotubes to a  similar extent as untransfected myoblasts 
(Figure 2 A). They also express muscle et-actinin, however, 
muscle et-actinin in the resulting myotubes does not orga- 
nize in striations (Fig. 3 E). Thus, ectopic expression of the 
a5Acyto deletion restores differentiation but does not sig- 
nificantly affect the  rate  of proliferation.  On  the  other 
hand, myoblasts transfected with the OL5CFFrR truncation, 
behave indistinguishably from hot5-transfected myoblasts. 
As determined by incorporation of BrdU, 80%  of myo- 
blasts expressing a5~FFKR remain in the proliferative phase 
(Fig. 4 D). Furthermore, fewer than 5% of the cells fuse 
into myotubes (Fig. 2 A) or express muscle ot-actinin (Fig. 
3 C). These results show that the ectopic a5 subunit inhib- 
its differentiation and promotes proliferation via its cyto- 
plasmic  domain  and  that  the  membrane  proximal  five 
amino acids are critical in this regulation. The effects of ec- 
topic a5 and et6 expression and cytoplasmic domain alter- 
ations on myoblast proliferation, differentiation, and myo- 
fibril assembly are summarized in Table I. 
Integrin Regulation of  Muscle Differentiation Is 
Modulated by Growth Factors 
While ectopic expression of the a5 integrin inhibits differ- 
entiation, if het5-transfected myoblasts are allowed to re- 
main as a confluent monolayer for at least one week to ten 
days, they synchronously fuse into myotubes and express 
muscle specific proteins (not shown). The spontaneous dif- 
ferentiation of long term,  high  density cultures  of hot5- 
transfected myoblasts suggests that sustained proliferation 
and  inhibition of differentiation might arise from an  al- 
tered sensitivity to serum growth factors. Marked differ- 
ences in serum requirements for the differentiation of un- 
transfected,  ha5-transfegted,  and  chicken ot6-transfected 
myoblasts support this hypothesis. The UT and chicken 
a6-transfected  myoblasts  exhibit  substantial  differentia- 
tion in a complete medium, containing a high serum con- 
centration and embryo extract (Fig. 2 A and B), as well as 
in low serum  (not shown) or serum-free conditions (UT 
only; Figs. 7 A  and 8 A). In contrast, the ha5-transfected 
myoblasts terminally differentiate only in a medium con- 
taining  less  than  ,-,2%  serum  (not shown)  including  se- 
rum-free conditions (Figs. 7 B and 8 A). Thus, a major ef- 
fect of ectopic et5 expression is an enhanced susceptibility 
to the proliferation promoting effects of serum growth fac- 
tors. 
We  next  compared  the  effects  of  individual  serum 
growth factors in the decision of the hot5-transfected myo- 
blasts to proliferate or differentiate under serum-free con- 
ditions. Addition of different, exogenous growth factors to 
ha5-transfected myoblasts in serum-free medium resulted 
in  distinct  effects  on  proliferation  and  differentiation 
which were not observed in UT controls. These effects are 
summarized  in  Table  II.  In  serum-free  medium  alone, 
nearly 60% of the hot5-transfected myoblasts fuse into myo- 
tubes after 48 h  (Fig. 8 A) and express muscle et-actinin. 
However, in contrast to untransfected cultures where mus- 
cle ot-actinin organizes in striations (Fig. 7 A), muscle et-acti- 
nin in differentiated ho~5 cultures is not organized in a stri- 
48 h in serum-free culture. (B) The ha5-transfected myoblasts fuse into myotubes and express muscle ct-actinin, however, unlike the un- 
transfected control, muscle et-actinin is not striated in these cultures, bFGF (D and D ") and TGF-I3 (F and F') inhibit muscle et-actinin 
expression and fusion into myotubes in ha5-transfected  myoblasts. TGF-tx (C) and PDGF-BB (E) enhance myofibril assembly in differ- 
entiated ha5 cultures. After 72 h, muscle ct-actinin is organized in striations in contrast to serum-free medium alone (B). (G) Insulin pro- 
motes fusion and muscle a-actinin  expression  in ha5-transfected  myoblasts but alters myotube morphology. The myotubes are fat, 
highly branched and muscle a-actinin organization is impaired. Bars: (D, D ', F, and F ~) 70 ~m; (A-C, E and G) 20 Ixm. 
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fewer than 5 % of hot5-transfected myoblasts fuse into my- 
otubes (Fig. 8 A) or express muscle ot-actinin (Fig. 7 D, D', 
F, F'). Thus, bFGF and TGF-[3 inhibit the serum-free dif- 
ferentiation  of ha5-transfected  myoblasts.  Furthermore, 
bFGF and TGF-[3 produce contrasting effects on prolifer- 
ation  of the  hot5-transfected myoblasts. 25-30%  of both 
untransfected and hot5-transfected cells incorporate BrdU 
in serum-free medium alone (which likely reflects residual 
growth factor activity) (Fig. 8 B). In contrast, 65% of hot5- 
transfected  myoblasts  treated  with  bFGF  incorporate 
BrdU. Hence, the presence of bFGF mimics the mitogenic 
effects of a rich medium and stimulates proliferation of the 
hot5-transfected  myoblasts.  Addition  of  TGF-[3,  on  the 
other  hand,  inhibits  proliferation  of the  het5-transfected 
myoblasts (Fig. 8 B). 
Addition  of either  insulin,  TGF-et, or  PDGF-BB  pro- 
duces  phenotypes  distinct  from those  just  described  for 
bFGF or TGF-B. Insulin promotes both proliferation and 
differentiation of the  hot5-transfected myoblasts, but has 
no measurable effect on untransfected cells. As shown in 
Fig.  8  B,  insulin  initially  stimulates  proliferation  in  50- 
60%  of ha5-transfected  myoblasts. After 48  h,  the  hot5- 
transfected myoblasts differentiate and 70% of the nuclei 
reside  in  myotubes  (Fig.  8  A).  The  resulting  myotubes 
however  are  abnormal;  they  are  short,  highly  branched 
and muscle ct-actinin is not organized in striations (Fig. 7 
G). TGF-et, like insulin, promotes proliferation, although 
to a  lesser extent (Fig. 8 B), as well as differentiation of 
het5-transfected myoblasts (Fig. 8 A). However, in contrast 
to insulin or serum-free conditions, TGF-a promotes the 
organization of muscle a-actinin in striations in the major- 
ity of het5-transfected myotubes (Fig. 7  C). Interestingly, 
among all  growth factors tested,  only TGF-ot stimulates 
proliferation of the untransfected  myoblasts growing un- 
der serum-free conditions (Fig. 8 B). PDGF-BB has no ef- 
fect on proliferation or on the serum-free differentiation 
of ha5-transfected myoblasts (Fig. 8 A  and B); however, 
like TGF-et, it promotes myofibril organization (Fig. 7 E). 
While  a  significant  fraction of untransfected  and  hot5- 
transfected myoblasts differentiated under serum-free condi- 
tions, those cells that did not differentiate survived poorly 
in the absence of serum or growth factors. After 24 h in se- 
rum-free culture, ~35-40% of both the untransfected and 
hot5-transfected  myoblasts  detached  from  the  substrate 
Figure 8.  Effect of exogenous  growth factors on proliferation, 
differentiation,  and survival of untransfected and ha5-transfected 
myoblasts.  Untransfected  and  h~t5-transfected  myoblasts were 
cultured  on FN-coated coverslips under serum-free conditions  in 
the presence or absence of individual growth factors and scored 
for (A) fusion after 48 h, (B) BrdU incorporation at 24 h, or (C) 
cell survival  at 24 h.  Cell  survival  is expressed as the  average 
number of nuclei per field with or without growth factor relative 
to serum-free conditions  alone. The data were scored from five 
random fields  and are representative of three separate experi- 
ments. The error bars correspond to the standard deviations  for 
different fields. (A) The fusion index, the percentage of nuclei re- 
siding in myotubes, shows that the hct5-transfected myoblasts dif- 
ferentiate substantially  after 48 h in the absence of serum.  The 
addition  of growth factors to the untransfected myoblasts (UT) 
does not affect their serum-free differentiation, bFGF and TGF-[3 
inhibit  fusion  of  the  ho.5-transfected  myoblasts  while  other 
growth factors have no effect.  (B) BrdU incorporation in  un- 
transfected (UT) and het5-transfected myoblasts after 24 h shows 
that bFGF and insulin stimulate proliferation of the het5-trans- 
fected myoblasts but not of untransfected myoblasts. TGF-I~ in- 
hibits  proliferation of both untransfected  and  hct5-transfected 
myoblasts while  TGF-a promotes proliferation of the untrans- 
fected and hotS-transfected  myoblasts to the same extent. PDGF-BB 
has no effect on proliferation.  (C) After 24 h in serum-free cul- 
ture, insulin and bFGF promote survival of the ho.5-transfected 
myoblasts while TGF-a and TGF-~3 promote survival of the un- 
transfected myoblasts. 
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Untransfected myoblasts 
Media  Myofibril  Myoblast 
condition  Proliferation  Differentiation  assembly  survival  Proliferation 
ha5-transfected myoblasts 
Differentiation 
Myofibfil 
assembly 
Myoblast 
survival 
Complete  +  +  +  +  +  -  NA  + 
medium 
Serum  -  +  +  -  -  +  -  - 
free 
Insulin  -  +  +  -  +  +  -  + 
bFGF  -  +  +  -  +  -  NA  + 
TGF-13  -  +  +  +  -  -  NA  - 
TGF-a  +  +  +  +  +  +  +  - 
PDGF-BB  -  +  +  -  -  +  +  - 
+, denotes that cells proliferate, differentiate, assemble myofibrils, or survive. 
-, denotes that cells display inhibited proliferation, differentiation, myofibril assembly, or survival. 
NA, not applicable. 
and underwent cell death including nuclear fragmentation 
and DNA degradation (not shown). The addition of differ- 
ent  growth factors to  either untransfected myoblasts or 
ha5-transfected myoblasts had differential effects on myo- 
blast survival. Insulin and bFGF promoted survival of the 
ha5-transfected myoblasts but not the untransfected myo- 
blasts (Fig. 8 C). TGF-a and TGF-13 enhanced the survival 
of the untransfected myoblasts but not the ha5-transfected 
myoblasts. PDGF-BB protected neither the untransfected 
nor the ha5-transfected myoblasts. Taken together, these 
results  demonstrate  that  growth  factors  elicit  different 
phenotypes for cell differentiation, proliferation, myofibril 
organization, and cell survival depending on the integrin 
background of the cells to which they are added. 
Discussion 
In this study, we addressed the role of integrins in muscle 
differentiation through  ectopic expression  of integrin  c~ 
subunits in primary skeletal muscle. Primary quail muscle 
is an attractive in vitro system both for the study of differ- 
entiation and for the ectopic expression of foreign genes. 
Since many aspects of muscle differentiation and develop- 
ment are rapidly and  faithfully reproduced in  these pri- 
mary cultures, this system enables us to determine the ef- 
fect of changes in integrin expression at multiple stages of 
myogenesis. Our results demonstrate the efficient, ectopic 
expression of integrin a  subunits  in  primary quail  myo- 
blasts.  The phenotypes we observe support the previous 
studies of Menko and Boettiger (1987) which suggest that 
131 integrins can regulate terminal muscle differentiation. 
We extend their studies by showing that different integrin 
subunits play distinct roles in regulating the transition 
from proliferation to terminal differentiation and in deter- 
mining aspects of the differentiated phenotype. These ef- 
fects appear to result from signaling events mediated by 
the integrin ~ subunit cytoplasmic domains. Our data fur- 
ther suggest that the differentiative phenotype is an inte- 
grated response to the signals  produced by the different 
integrins expressed on the cell surface and the signals aris- 
ing from the growth factor environment in which the cells 
reside. In this context, cell lines, which possess activated 
signaling pathways, may show responses to different inte- 
grins, matrix composition, and growth factors that differ 
from those in primary cells. 
Several previous studies implicate the a5131 integrin in 
signaling events that regulate cell proliferation (Giancotti 
and Ruoslahti,  1990;  Varner et al.,  1995), differentiation 
(Adams and Watt, 1990; Boettiger et al.,  1995; Hotchin et 
al., 1993), and apoptosis (Zhang et al., 1995). The e~5131 in- 
tegrin participates in signal transduction events leading to 
induction  of metalloproteinase expression in  rabbit  syn- 
ovial fibroblasts (Werb et al.,  1989)  and to changes in im- 
mediate early gene expression that correlate with prolifer- 
ation  (Varner  et  al.,  1995).  Overexpression  of  the  a5 
integrin in transformed cell lines suppresses tumorigenic- 
ity and anchorage-independent proliferation but promotes 
proliferation  upon  substrate  attachment  (Giancotti  and 
Ruoslahti,  1990; Varner et al., 1995).  These findings sug- 
gest  that  the  signals  mediated by the a5  subunit,  which 
positively signal proliferation in cells adherent to FN and 
negatively regulate growth in suspension, depend on the 
state of ligation, i.e., conformation or activation state, of 
the c~5131 heterodimer (Varner et al., 1995).  Our findings 
support a role for the a5 integrin in promoting anchorage- 
dependent proliferation. Cell attachment to FN via the a5 
integrin also promotes cell survival (Zhang et al.,  1995). 
CHO cells that do not express the oL5 subunit undergo ap- 
optosis in the absence of serum. Surprisingly, ectopic ex- 
pression of the et5 subunit in our system does not spare 
myoblasts from cell death in serum-free conditions despite 
the presence of a  FN substrate.  Thus, cell attachment is 
not sufficient to protect myoblasts from cell death.  Pre- 
sumably a5 regulation of cell survival is cell-type depen- 
dent. However, as discussed below, ectopic a5 expression 
does affect both myoblast proliferation and survival when 
myoblasts are grown in the presence of particular growth 
factors. 
The a5131 integrin  also  plays  an  important regulatory 
role during differentiation. A  functional inactivation, re- 
sulting in a decreased adhesion to FN and downregulation, 
of the oL5131 integrin coincides with keratinocyte differenti- 
ation  (Adams  and  Watt,  1990;  Hotchin, et al.,  1993).  In 
muscle, a5131 is subject to regulation early in myogenesis 
suggesting  an involvement in  its terminal differentiation 
(Enomoto et al.,  1993; Lakonishok et al.,  1992; Blaschuk 
and Holland, 1994). The a5131 integrin is expressed in pro- 
liferating myoblasts but is downregulated upon induction 
of terminal differentiation. This observation suggests that 
continuous, high-level expression of the a5 integrin coin- 
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vations. There is also evidence that changes in the activa- 
tion state of the et5 integrin regulate muscle differentiation 
(Boettiger et al., 1995). Our experiments confirm and ex- 
tend these previous studies implicating the or5 integrin in 
myogenesis by demonstrating that the expression level of 
the o~5 subunit can affect the proliferative to differentia- 
tive transition and organization of myofibrils. 
In contrast to the or5 subunit, considerably less is known 
regarding  the  biological function of the  et6  integrin.  In 
many systems, the et6 integrin is functionally inactive as a 
laminin receptor. For example, in macrophages (Shaw et 
al., 1990)  and K562 erythroleukemic cells (Delwel et al., 
1993),  the adhesive function of et6 requires activation by 
phorbol esters. In addition, upon attachment of activated 
macrophages to LM, the et6 integrin participates in signal 
transduction leading to differential tyrosine phosphoryla- 
tion of several proteins, which depends on the particular 
cytoplasmic domain isoform expressed (Shaw et al., 1995). 
Thus, the et6 integrin is subject to cellular regulation and 
also acts as a signaling receptor. Our data not only point to 
a potential role for the et5 integrin in differentiation, they 
also demonstrate a  potential role for the or6 integrin in 
myogenesis. While ectopic expression of the et5 subunit in- 
hibits differentiation and maintains myoblasts in the pro- 
liferative phase, ectopic or6 expression inhibits prolifera- 
tion  but  not  differentiation.  Antisense  suppression  of 
endogenous et6 expression inhibits differentiation and pro- 
motes proliferation. 
Taken together, the effects of ectopic or5 and et6 expres- 
sion and antisense inhibition of or6 expression on myoblast 
proliferation and differentiation show that perturbing the 
existing ratio of et5- and oL6-expression affects the decision 
of myoblasts to proliferate or differentiate. The ratio also 
appears  to  contribute  to  myofibrillar organization since 
the degree of myofibrillar striation differs in a5- and et6- 
transfected cells. The opposing effects of a5 and or6 expres- 
sion on myoblast proliferation and differentiation demon- 
strate a reciprocity between these two integrin subunits and 
is consistent with previous studies which show an inverse 
relationship between et5  and et6 expression during chick 
embryo development (Bronner-Fraser et al., 1992; Musch- 
ler and Horwitz, 1991).  However, it is premature to con- 
clude that the ratio of et5/a6 expression, per se, is a physio- 
logical regulator of muscle differentiation. We conclude 
only that changes in integrin ratios can regulate the differ- 
entiative state. The relative expression of other integrins 
also contributes to the proliferative to differentiative tran- 
sition. Thus, integrin regulation of differentiation is best 
viewed as an integrated response to the relative expression 
levels of multiple integrins. An analogous example of com- 
plementary signaling is observed with the ~t5~l and et4131 
integrins in regulating expression of metalloproteinases in 
rabbit synovial fibroblasts (Huhtala et al., 1995). 
How do these integrins act to regulate differentiation? 
Several observations suggest that the effects of ectopic oL5 
and or6 expression are mediated by the ct subunit cytoplas- 
mic domain through signal transduction processes. The in- 
hibitory effect of et5ex/6  cyt° expression on myoblast prolif- 
eration and the maintenance of the proliferative phase by 
expression of Ct6ex/5  eyt° show that the or6 cytoplasmic do- 
main  is  involved  in  negative  regulation  of cell  growth 
whereas the o~5 cytoplasmic domain transmits proliferative 
signals. We also show that the conserved, membrane prox- 
imal, GFFKR sequence in the or5 cytoplasmic domain is a 
critical element in the regulation of differentiation via the 
or5 subunit. The GFFKR sequence regulates the affinity of 
the alIb~3 integrin for fibrinogen (O'Toole et al., 1991). 
In our system, the role of receptor activation and ligation 
in mediating the  effects of ectopic et5  or et6  is  unclear. 
Both the et5 and Ot5GFF~R-transfected  myoblasts, which do 
not differentiate, and the ot5Acyto and the ot5ex/6CYt°-trans  - 
fected myoblasts which do differentiate, adhere similarly 
to a FN substrate and organize cell surface FN similarly 
(Sastry,  S.,  and  M.  Lakonishok,  unpublished  results). 
However, since these cells secrete FN, it is difficult to test 
the effects of a single ligand on differentiation. It is also 
possible that ectopic et5 expression leads to a change in the 
expression of other integrin subunits  either by replace- 
ment of endogenous et subunits by the ectopic et5 subunit 
or by the downregulation of another ot subunit. However, 
surface immunoprecipitations of IM integrins from ot5-trans- 
fected myoblasts do not reveal major changes in the pro- 
file of a  subunits that associate with the 131 subunit when 
compared  to  those  present  in  untransfected myoblasts. 
Among specific ot  subunits  for which  suitable  antibody 
probes are available, the level of endogenous quail et5, a6, 
and a3 expression do not change significantly as a result of 
ectopic or5 expression (Lakonishok, M., and S. Sastry, un- 
published results). We do, however, observe a twofold in- 
crease in the total amount of surface 131 and a four to five- 
fold increase in the total amount of surface or5 expressed 
in the hot5-transfected myoblasts. 
Thus, the most likely explanation for our results is that 
the  integrins  activate  signaling pathways which interact 
with growth factor signaling pathways. It is interesting to 
note that v-src-transformed  myoblasts possess  a  pheno- 
type (Alema and Tato, 1987)  similar to that of the hot5- 
transfected myoblasts in our study. Our preliminary stud- 
ies  show significant tyrosine phosphorylation of several 
proteins with molecular masses in the ranges of 30-34 kD, 
60-70 kD, and 120 kD in ot5-transfected myoblasts grown 
in a  rich medium but not in untransfected controls (La- 
konishok, M., unpublished results). While FAK stands out 
as an obvious point of convergence between integrin, src- 
kinases, and growth factor mediated signal transduction 
pathways (Schlaepfer et al., 1994; Zachary and Rozengurt, 
1992), we have not observed changes in its tyrosine phos- 
phorylation that correlate  with differentiation. Interest- 
ingly, in serum-free conditions, where et5-transfected myo- 
blasts  terminally differentiate, the  or5  induced  tyrosine 
phosphorylations are suppressed suggesting that et5-medi- 
ated signaling depends on the activation of growth factor 
signaling pathways. 
An extensive literature points to growth factors as criti- 
cal regulators  of myogenesis (Florini and Magri,  1989). 
Our observations demonstrate that growth factor regula- 
tion  depends  on  the  particular  integrins  present.  This 
points to an interaction between integrin and growth fac- 
tor signaling pathways, the consequence of which is that 
integrin regulation of differentiation depends on the pre- 
cise growth factor environment and vice versa. For exam- 
ple, the ectopic expression of different integrins shifts the 
serum response of myoblasts to favor either the prolifera- 
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hances myoblast susceptibility to the mitogenic factors in 
serum whereas  ectopic et6  expression abrogates  it.  Fur- 
thermore, ectopic or5 expression alters the response to in- 
dividual growth factors uniquely to influence differentia- 
tion at multiple stages. Similar treatment of untransfected 
myoblasts does not measurably alter their serum-free dif- 
ferentiation, bFGF, for example, influences the transition 
from proliferation to differentiation by stimulating prolif- 
eration  and  inhibiting  differentiation in  the  het5-trans- 
fected myoblasts but not in untransfected cells. Insulin, in 
contrast, promotes both proliferation and differentiation; 
but the resulting myotubes display an altered morphology 
and poorly organized myofibrils. PDGF, while having no 
detectable effect on the decision of et5-transfected myo- 
blasts  to proliferate or differentiate, enhances myofibril 
assembly.  TGF-a  is  unique  among  the  growth  factors 
tested in  that it stimulates proliferation, differentiation, 
and myofibrillar assembly. It produces a phenotype in the 
ot5-transfected myoblasts that most closely resembles un- 
transfected myoblasts grown in a rich medium. The effects 
of insulin on myotube morphology and TGF-a and PDGF 
on  myofibrillar  assembly  also  demonstrate  that  these 
events are regulated, at least in part, by signaling mecha- 
nisms and point to a role for integrin-growth factor cou- 
pled  signaling  in  muscle  morphogenesis.  Although  the 
mechanism by which muscle ot-actinin becomes striated in 
the presence of TGF-a or PDGF is unclear, it should be 
noted that the organization of other cytoskeletal compo- 
nents like titin and myosin heavy chain are not altered by 
ectopic a5  expression (Lakonishok, M., unpublished re- 
sults). Finally, it is interesting that the growth factor ef- 
fects on het5-transfected, rather than untransfected cells, 
most closely resemble those described in the literature for 
muscle cell lines (Florini and Magri, 1989). 
The ectopically expressed et5 8ubunit and growth factors 
also interact to affect cell survival, a process that is also the 
result of a signal transduction pathway (Yuan, 1995; Earn- 
shaw, 1995).  Ectopic or5 expression does not spare myo- 
blasts from cell death in the absence of serum despite en- 
hanced attachment of the ot5-transfected myoblasts to FN 
compared to untransfected myoblasts. Thus, cell attach- 
ment is not sufficient to promote myoblast survival. How- 
ever, the addition of insulin or bFGF protects het5-trans- 
fected myoblasts from cell death but does not enhance the 
survival of untransfected myoblasts. In contrast, TGF-et 
and TGF-I~  protect the untransfected myoblasts but not 
the hot5-transfected myoblasts. Therefore, different growth 
factors differentially  influence cell survival of untransfected 
and her5 transfected myoblasts, demonstrating further that 
ectopic et5 expression changes the growth factor response. 
Our  biological  observations  complement  recent  bio- 
chemical evidence that demonstrates a coupling between 
integrin and growth factor signaling pathways (Yamada 
and Miyamoto, 1995). Integrin engagement is required for 
PDGF-induced  inositol  lipid  breakdown  in  fibroblasts 
(McNamee et al., 1993) and for the association of a novel 
tyrosine phosphorylated protein with integrin (Bartfeld et 
al., 1993). In addition, a physical association between IRS-1, 
a component of the insulin signaling pathway, and the etv133 
integrin after ligation of the insulin receptor has been demon- 
strated (Vuori and Ruoslahti, 1994). Another recent report 
shows that cell attachment to fibronectin causes focal ad- 
hesion kinase to associate with proteins in the growth factor- 
activated Ras/MAP kinase signaling pathway (Schlaepfer 
et al., 1994). 
In summary, the results presented here provide clear bi- 
ological evidence that integrins and growth factors act to- 
gether to regulate muscle differentiation. Our data lead to 
the following conclusions about the role of integrins and 
growth factors in regulating muscle differentiation. First, 
different integrins initiate characteristic signals to differ- 
entially affect proliferation and differentiation. The ratio 
of the different integrins expressed and their ligation state 
are the key parameters. Second, the growth factor envi- 
ronment in which the cell resides influences the integrin 
mediated signals to uniquely regulate differentiation, pro- 
liferation, cytoskeletal assembly, and cell survival. Third, 
in the  absence  of a  mitogenic stimulus, i.e.,  serum-free 
conditions, myoblasts differentiate suggesting that differ- 
entiation is the default pathway. Those myoblasts which 
are unable to differentiate undergo cell death. Fourth, the 
precise cellular phenotype is a combinatorial response re- 
sulting from an integration of signals emanating from spe- 
cific integrins and particular  growth factors. Thus, inte- 
grins appear in many respects as functionally equivalent to 
growth factor receptors. 
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